{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:09:20Z","timestamp":1790644160371,"version":"4.1.0"},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Immunodeficiency, centromeric instability and facial dysmorphism (ICF) syndrome is a rare autosomal recessive immune disorder presenting with hypogammaglobulinemia, developmental delay, and facial anomalies. The ICF type 1, type 2, type 3 and type 4 are characterized by mutations in DNMT3B, ZBTB24, CDCA7 or HELLS gene, respectively. This study aimed to present a comprehensive description of the clinical, immunologic and genetic features of patients with ICF syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>PubMed, Web of Science, and Scopus were searched systemically to find eligible studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Forty-eight studies with 118 ICF patients who met the inclusion criteria were included in our study. Among these patients, 60% reported with ICF-1, 30% with ICF-2, 4% with ICF-3, and 6% with ICF-4. The four most common symptoms reported in patients with ICF syndrome were: delay in motor development, low birth weight, chronic infections, and diarrhea. Intellectual disability and preterm birth among patients with ICF-2 and failure to thrive, sepsis and fungal infections among patients with ICF-1 were also more frequent. Moreover, the median levels of all three immunoglobulins (IgA, IgG, IgM) were markedly reduced within four types of ICF syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The frequency of diagnosed patients with ICF syndrome has increased. Early diagnosis of ICF is important since immunoglobulin supplementation or allogeneic stem cell transplantation can improve the disease-free survival rate.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871530320666200613204426","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T20:29:28Z","timestamp":1592080168000},"page":"664-672","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review"],"prefix":"10.2174","volume":"21","author":[{"given":"Fatemeh","family":"Kiaee","sequence":"first","affiliation":[{"name":"Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Zaki-Dizaji","sequence":"additional","affiliation":[{"name":"Legal Medicine Research Center, Legal Medicine Organization, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Hafezi","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Almasi-Hashiani","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Hamedifar","sequence":"additional","affiliation":[{"name":"CinnaGen Medical Biotechnology Research Center, Alborz University of medical sciences, Karaj,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araz","family":"Sabzevari","sequence":"additional","affiliation":[{"name":"CinnaGen Medical Biotechnology Research Center, Alborz University of medical sciences, Karaj,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Shirkani","sequence":"additional","affiliation":[{"name":"Allergy and clinical Immunology Department, School of Medicine, Bushehr University of Medical Science, Bushehr,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeineb","family":"Zian","sequence":"additional","affiliation":[{"name":"Biomedical Genomics and Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier, Abdelmalek Essaadi University, Tetouan,Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[{"name":"Immunology Research Center, Tabriz University of Medical Sciences, Tabriz,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Aghamahdi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Goudarzvand","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Faculty of Medicine, Alborz University of Medical Sciences, Karaj,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm,Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/epi.20523","volume":"7","author":"Heyn H.","year":"2012","unstructured":"Heyn H.; Vidal E.; Sayols S.; Sanchez-Mut J.V.; Moran S.; Medina I.; Sandoval J.; Sim\u00f3-Riudalbas L.; Szczesna K.; Huertas D.; Gatto S.; Matarazzo M.R.; Dopazo J.; Esteller M.; Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient. Epigenetics 2012,7(6),542-550","journal-title":"Epigenetics"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/08916930802024202","volume":"41","author":"Ehrlich M.","year":"2008","unstructured":"Ehrlich M.; Sanchez C.; Shao C.; Nishiyama R.; Kehrl J.; Kuick R.; Kubota T.; Hanash S.M.; ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity 2008,41(4),253-271","journal-title":"Autoimmunity"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1871530319666190828125316","volume":"20","author":"Tavakol M.","year":"2020","unstructured":"Tavakol M.; Jamee M.; Azizi G.; Sadri H.; Bagheri Y.; Zaki-Dizaji M.; Mahdavi F.S.; Jadidi-Niaragh F.; Tajfirooz S.; Kamali A.N.; Aghamahdi F.; Noorian S.; Kojidi H.T.; Mosavian M.; Matani R.; Dolatshahi E.; Porrostami K.; Elahimehr N.; Fatemi-Abhari M.; Sharifi L.; Arjmand R.; Haghi S.; Zainaldain H.; Yazdani R.; Shaghaghi M.; Abolhassani H.; Aghamohammadi A.; Diagnostic approach to the patients with suspected primary immunodeficiency. Endocr Metab Immune Disord Drug Targets 2020,20(2),157-171","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/jmg.25.3.173","volume":"25","author":"Maraschio P.","year":"1988","unstructured":"Maraschio P.; Zuffardi O.; Dalla Fior T.; Tiepolo L.; Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet 1988,25(3),173-180","journal-title":"J Med Genet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"14412","DOI":"10.1073\/pnas.96.25.14412","volume":"96","author":"Hansen R.S.","year":"1999","unstructured":"Hansen R.S.; Wijmenga C.; Luo P.; Stanek A.M.; Canfield T.K.; Weemaes C.M.; Gartler S.M.; The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA 1999,96(25),14412-14417","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ejhg.2013.40","volume":"21","author":"Weemaes C.M.","year":"2013","unstructured":"Weemaes C.M.; van Tol M.J.; Wang J.; van Ostaijen-ten Dam M.M.; van Eggermond M.C.; Thijssen P.E.; Aytekin C.; Brunetti-Pierri N.; van der Burg M.; Graham Davies E.; Ferster A.; Furthner D.; Gimelli G.; Gennery A.; Kloeckener-Gruissem B.; Meyn S.; Powell C.; Reisli I.; Schuetz C.; Schulz A.; Shugar A.; van den Elsen P.J.; van der Maarel S.M.; Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet 2013,21(11),1219-1225","journal-title":"Eur J Hum Genet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ajhg.2011.04.018","volume":"88","author":"de Greef J.C.","year":"2011","unstructured":"de Greef J.C.; Wang J.; Balog J.; den Dunnen J.T.; Frants R.R.; Straasheijm K.R.; Aytekin C.; van der Burg M.; Duprez L.; Ferster A.; Gennery A.R.; Gimelli G.; Reisli I.; Schuetz C.; Schulz A.; Smeets D.F.C.M.; Sznajer Y.; Wijmenga C.; van Eggermond M.C.; van Ostaijen-Ten Dam M.M.; Lankester A.C.; van Tol M.J.D.; van den Elsen P.J.; Weemaes C.M.; van der Maarel S.M.; Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet 2011,88(6),796-804","journal-title":"Am J Hum Genet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1038\/ncomms8870","volume":"6","author":"Thijssen P.E.","year":"2015","unstructured":"Thijssen P.E.; Ito Y.; Grillo G.; Wang J.; Velasco G.; Nitta H.; Unoki M.; Yoshihara M.; Suyama M.; Sun Y.; Lemmers R.J.; de Greef J.C.; Gennery A.; Picco P.; Kloeckener-Gruissem B.; G\u00fcng\u00f6r T.; Reisli I.; Picard C.; Kebaili K.; Roquelaure B.; Iwai T.; Kondo I.; Kubota T.; van Ostaijen-Ten Dam M.M.; van Tol M.J.; Weemaes C.; Francastel C.; van der Maarel S.M.; Sasaki H.; Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome. Nat Commun 2015,6,7870","journal-title":"Nat Commun"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fimmu.2011.00054","volume":"2","author":"Al-Herz W.","year":"2011","unstructured":"Al-Herz W.; Bousfiha A.; Casanova J.L.; Chapel H.; Conley M.E.; Cunningham-Rundles C.; Etzioni A.; Fischer A.; Franco J.L.; Geha R.S.; Hammarstr\u00f6m L.; Nonoyama S.; Notarangelo L.D.; Ochs H.D.; Puck J.M.; Roifman C.M.; Seger R.; Tang M.L.; Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011,2,54","journal-title":"Front Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/jmg.2007.053397","volume":"45","author":"Hagleitner M.M.","year":"2008","unstructured":"Hagleitner M.M.; Lankester A.; Maraschio P.; Hult\u00e9n M.; Fryns J.P.; Schuetz C.; Gimelli G.; Davies E.G.; Gennery A.; Belohradsky B.H.; de Groot R.; Gerritsen E.J.; Mattina T.; Howard P.J.; Fasth A.; Reisli I.; Furthner D.; Slatter M.A.; Cant A.J.; Cazzola G.; van Dijken P.J.; van Deuren M.; de Greef J.C.; van der Maarel S.M.; Weemaes C.M.; Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet 2008,45(2),93-99","journal-title":"J Med Genet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1172-1-2","volume":"1","author":"Ehrlich M.","year":"2006","unstructured":"Ehrlich M.; Jackson K.; Weemaes C.; Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 2006,1,2","journal-title":"Orphanet J Rare Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"10034","DOI":"10.1093\/nar\/gky682","volume":"46","author":"Thompson J.J.","year":"2018","unstructured":"Thompson J.J.; Kaur R.; Sosa C.P.; Lee J.H.; Kashiwagi K.; Zhou D.; Robertson K.D.; ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation. Nucleic Acids Res 2018,46(19),10034-10051","journal-title":"Nucleic Acids Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"Jho E.H.","year":"2002","unstructured":"Jho E.H.; Zhang T.; Domon C.; Joo C.K.; Freund J.N.; Costantini F.; Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002,22(4),1172-1183","journal-title":"Mol Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/emboj\/17.5.1371","volume":"17","author":"Ikeda S.","year":"1998","unstructured":"Ikeda S.; Kishida S.; Yamamoto H.; Murai H.; Koyama S.; Kikuchi A.; Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998,17(5),1371-1384","journal-title":"EMBO J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s11481-012-9404-x","volume":"7","author":"Mulligan K.A.","year":"2012","unstructured":"Mulligan K.A.; Cheyette B.N.; Wnt signaling in vertebrate neural development and function. J Neuroimmune Pharmacol 2012,7(4),774-787","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jor.20954","volume":"28","author":"Dao D.Y.","year":"2010","unstructured":"Dao D.Y.; Yang X.; Flick L.M.; Chen D.; Hilton M.J.; O\u2019Keefe R.J.; Axin2 regulates chondrocyte maturation and axial skeletal development. J Orthop Res 2010,28(1),89-95","journal-title":"J Orthop Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1172\/JCI70372","volume":"124","author":"Tucci V.","year":"2014","unstructured":"Tucci V.; Kleefstra T.; Hardy A.; Heise I.; Maggi S.; Willemsen M.H.; Hilton H.; Esapa C.; Simon M.; Buenavista M.T.; McGuffin L.J.; Vizor L.; Dodero L.; Tsaftaris S.; Romero R.; Nillesen W.N.; Vissers L.E.; Kempers M.J.; Vulto-van Silfhout A.T.; Iqbal Z.; Orlando M.; Maccione A.; Lassi G.; Farisello P.; Contestabile A.; Tinarelli F.; Nieus T.; Raimondi A.; Greco B.; Cantatore D.; Gasparini L.; Berdondini L.; Bifone A.; Gozzi A.; Wells S.; Nolan P.M.; Dominant \u03b2-catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest 2014,124(4),1468-1482","journal-title":"J Clin Invest"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/dev.128.8.1253","volume":"128","author":"Brault V.","year":"2001","unstructured":"Brault V.; Moore R.; Kutsch S.; Ishibashi M.; Rowitch D.H.; McMahon A.P.; Sommer L.; Boussadia O.; Kemler R.; Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001,128(8),1253-1264","journal-title":"Development"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1242\/dev.01786","volume":"132","author":"Yu H.M.","year":"2005","unstructured":"Yu H.M.; Jerchow B.; Sheu T.J.; Liu B.; Costantini F.; Puzas J.E.; Birchmeier W.; Hsu W.; The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 2005,132(8),1995-2005","journal-title":"Development"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10815-015-0523-1","volume":"32","author":"Mafra F.","year":"2015","unstructured":"Mafra F.; Catto M.; Bianco B.; Barbosa C.P.; Christofolini D.; Association of WNT4 polymorphisms with endometriosis in infertile patients. J Assist Reprod Genet 2015,32(9),1359-1364","journal-title":"J Assist Reprod Genet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bpobgyn.2018.05.003","volume":"52","author":"Zhang G.","year":"2018","unstructured":"Zhang G.; Srivastava A.; Bacelis J.; Juodakis J.; Jacobsson B.; Muglia L.J.; Genetic studies of gestational duration and preterm birth. Best Pract Res Clin Obstet Gynaecol 2018,52,33-47","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3389\/fimmu.2018.02532","volume":"9","author":"Sjaastad F.V.","year":"2018","unstructured":"Sjaastad F.V.; Condotta S.A.; Kotov J.A.; Pape K.A.; Dail C.; Danahy D.B.; Kucaba T.A.; Tygrett L.T.; Murphy K.A.; Cabrera-Perez J.; Waldschmidt T.J.; Badovinac V.P.; Griffith T.S.; Polymicrobial sepsis chronic immunoparalysis is defined by diminished Ag-specific T cell-dependent B cell responses. Front Immunol 2018,9,2532","journal-title":"Front Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00281-014-0466-0","volume":"37","author":"Elluru S.R.","year":"2015","unstructured":"Elluru S.R.; Kaveri S.V.; Bayry J.; The protective role of immunoglobulins in fungal infections and inflammation. Semin Immunopathol 2015,37(2),187-197","journal-title":"Semin Immunopathol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","volume":"11","author":"Casadevall A.","year":"2012","unstructured":"Casadevall A.; Pirofski L.A.; Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 2012,11(5),447-456","journal-title":"Cell Host Microbe"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/eji.200323790","volume":"33","author":"Montagnoli C.","year":"2003","unstructured":"Montagnoli C.; Bozza S.; Bacci A.; Gaziano R.; Mosci P.; Morschh\u00e4user J.; Pitzurra L.; Kopf M.; Cutler J.; Romani L.; A role for antibodies in the generation of memory antifungal immunity. Eur J Immunol 2003,33(5),1193-1204","journal-title":"Eur J Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/IAI.68.12.7049-7060.2000","volume":"68","author":"Rodrigues M.L.","year":"2000","unstructured":"Rodrigues M.L.; Travassos L.R.; Miranda K.R.; Franzen A.J.; Rozental S.; de Souza W.; Alviano C.S.; Barreto-Bergter E.; Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect Immun 2000,68(12),7049-7060","journal-title":"Infect Immun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1128\/IAI.00278-07","volume":"75","author":"Rachini A.","year":"2007","unstructured":"Rachini A.; Pietrella D.; Lupo P.; Torosantucci A.; Chiani P.; Bromuro C.; Proietti C.; Bistoni F.; Cassone A.; Vecchiarelli A.; An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 2007,75(11),5085-5094","journal-title":"Infect Immun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1172\/JCI38322","volume":"120","author":"McClelland E.E.","year":"2010","unstructured":"McClelland E.E.; Nicola A.M.; Prados-Rosales R.; Casadevall A.; Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J Clin Invest 2010,120(4),1355-1361","journal-title":"J Clin Invest"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10875-018-0559-y","volume":"38","author":"Kamae C.","year":"2018","unstructured":"Kamae C.; Imai K.; Kato T.; Okano T.; Honma K.; Nakagawa N.; Yeh T.W.; Noguchi E.; Ohara A.; Shigemura T.; Takahashi H.; Takakura S.; Hayashi M.; Honma A.; Watanabe S.; Shigemori T.; Ohara O.; Sasaki H.; Kubota T.; Morio T.; Kanegane H.; Nonoyama S.; Clinical and immunological characterization of ICF syndrome in Japan. Clinical and immunological characterization of ICF syndrome in Japan. J Clin Immunol 2018,38(8),927-937","journal-title":"J Clin Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13023-014-0116-6","volume":"9","author":"von Bernuth H.","year":"2014","unstructured":"von Bernuth H.; Ravindran E.; Du H.; Fr\u00f6hler S.; Strehl K.; Kr\u00e4mer N.; Issa-Jahns L.; Amulic B.; Ninnemann O.; Xiao M.S.; Eirich K.; K\u00f6lsch U.; Hauptmann K.; John R.; Schindler D.; Wahn V.; Chen W.; Kaindl A.M.; Combined immunodeficiency develops with age in Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2). Orphanet J Rare Dis 2014,9,116","journal-title":"Orphanet J Rare Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/gene.2016.18","volume":"17","author":"Liang J.","year":"2016","unstructured":"Liang J.; Yan R.; Chen G.; Feng J.; Wu W.W.; Ren W.; Zhu C.; Zhao Y.; Gao X.M.; Wang J.; Downregulation of ZBTB24 hampers the G0\/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells. Genes Immun 2016,17(5),276-282","journal-title":"Genes Immun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2018.00580","volume":"9","author":"Zhu C.","year":"2018","unstructured":"Zhu C.; Chen G.; Zhao Y.; Gao X.M.; Wang J.; Regulation of the development and function of B cells by ZBTB transcription factors. Front Immunol 2018,9,580","journal-title":"Front Immunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1182\/blood-2003-08-2632","volume":"103","author":"Blanco-Betancourt C.E.","year":"2004","unstructured":"Blanco-Betancourt C.E.; Moncla A.; Milili M.; Jiang Y.L.; Viegas-P\u00e9quignot E.M.; Roquelaure B.; Thuret I.; Schiff C.; Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood 2004,103(7),2683-2690","journal-title":"Blood"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1042\/EBC20190035","volume":"63","author":"Vukic M.","year":"2019","unstructured":"Vukic M.; Daxinger L.; DNA methylation in disease: immunodeficiency, centromeric instability, facial anomalies syndrome. Essays Biochem 2019,63(6),773-783","journal-title":"Essays Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fimmu.2017.00429","volume":"8","author":"Scheer S.","year":"2017","unstructured":"Scheer S.; Zaph C.; The lysine methyltransferase G9a in immune cell differentiation and function. Front Immunol 2017,8,429","journal-title":"Front Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1750-1172-9-56","volume":"9","author":"Velasco G.","year":"2014","unstructured":"Velasco G.; Walton E.L.; Sterlin D.; H\u00e9douin S.; Nitta H.; Ito Y.; Fouyssac F.; M\u00e9garban\u00e9 A.; Sasaki H.; Picard C.; Francastel C.; Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology. Orphanet J Rare Dis 2014,9,56","journal-title":"Orphanet J Rare Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10875-016-0240-2","volume":"36","author":"Sterlin D.","year":"2016","unstructured":"Sterlin D.; Velasco G.; Moshous D.; Touzot F.; Mahlaoui N.; Fischer A.; Suarez F.; Francastel C.; Picard C.; Genetic, cellular and clinical features of ICF syndrome: a French national survey. J Clin Immunol 2016,36(2),149-159","journal-title":"J Clin Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/ajmg.a.35486","volume":"158A","author":"Cerbone M.","year":"2012","unstructured":"Cerbone M.; Wang J.; Van der Maarel S.M.; D\u2019Amico A.; D\u2019Agostino A.; Romano A.; Brunetti-Pierri N.; Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst. Am J Med Genet A 2012,158A(8),2043-2046","journal-title":"Am J Med Genet A"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/jhg.2013.56","volume":"58","author":"Nitta H.","year":"2013","unstructured":"Nitta H.; Unoki M.; Ichiyanagi K.; Kosho T.; Shigemura T.; Takahashi H.; Velasco G.; Francastel C.; Picard C.; Kubota T.; Sasaki H.; Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients. J Hum Genet 2013,58(7),455-460","journal-title":"J Hum Genet"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/182765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182765\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/182765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:49:49Z","timestamp":1723045789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182765\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320666200613204426","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}